BMS-978587 (BMS978587; IDO-IN-4) is a novel and potent indoleamine 2,3-dioxygenase 1 (IDO-1) inhibitor with anticancer and immunompdulatory activity. Extracted from patent WO2014150677A1, Compound example 1 enantiomer 1.
Physicochemical Properties
| Molecular Formula | C26H35N3O3 |
| Molecular Weight | 437.574406862259 |
| Exact Mass | 437.267 |
| CAS # | 1629125-65-0 |
| PubChem CID | 118676157 |
| Appearance | Off-white to yellow solid powder |
| Density | 1.2±0.1 g/cm3 |
| Boiling Point | 532.6±50.0 °C at 760 mmHg |
| Flash Point | 275.9±30.1 °C |
| Vapour Pressure | 0.0±1.5 mmHg at 25°C |
| Index of Refraction | 1.633 |
| LogP | 5.74 |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 9 |
| Heavy Atom Count | 32 |
| Complexity | 620 |
| Defined Atom Stereocenter Count | 2 |
| SMILES | CC1=CC=C(C=C1)NC(=O)NC2=C(C=CC(=C2)[C@H]3C[C@H]3C(=O)O)N(CC(C)C)CC(C)C |
| InChi Key | VZYCPKLOYXSKAB-FGZHOGPDSA-N |
| InChi Code | InChI=1S/C26H35N3O3/c1-16(2)14-29(15-17(3)4)24-11-8-19(21-13-22(21)25(30)31)12-23(24)28-26(32)27-20-9-6-18(5)7-10-20/h6-12,16-17,21-22H,13-15H2,1-5H3,(H,30,31)(H2,27,28,32)/t21-,22-/m1/s1 |
| Chemical Name | (1R,2S)-2-[4-[bis(2-methylpropyl)amino]-3-[(4-methylphenyl)carbamoylamino]phenyl]cyclopropane-1-carboxylic acid |
| HS Tariff Code | 2934.99.9001 |
| Storage |
Powder-20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
| Shipping Condition | Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs) |
Biological Activity
| ln Vitro | In human IDO1/HEK293 cells, BMS-978587 (IDO-IN-4) (Compound Example 1 Enantiomer 1) functions as an IDO-1 inhibitor [1]. |
| References |
[1]. Preparation of cycloalkylaryl amide compounds as indoleamine 2,3-dioxygenase and therapeutic uses thereof. From PCT Int. Appl. (2014), WO 2014150677 A1 20140925. |
Solubility Data
| Solubility (In Vitro) | DMSO : ≥ 100 mg/mL (~228.53 mM) |
| Solubility (In Vivo) |
Solubility in Formulation 1: ≥ 2.5 mg/mL (5.71 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL. Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution. Solubility in Formulation 2: ≥ 2.5 mg/mL (5.71 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly.  (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 2.2853 mL | 11.4267 mL | 22.8535 mL | |
| 5 mM | 0.4571 mL | 2.2853 mL | 4.5707 mL | |
| 10 mM | 0.2285 mL | 1.1427 mL | 2.2853 mL |